Results 151 to 160 of about 8,274 (166)

Mepolizumab Versus Benralizumab for Eosinophilic Granulomatosis With Polyangiitis (EGPA): A European Real-Life Retrospective Comparative Study [PDF]

Journal of Autoimmunity
Following the results of the MANDARA trial, this real-life study aimed at comparing the effectiveness and safety profile of mepolizumab versus benralizumab in a European EGPA cohort.
Silvestri Elena, Philippe Bonniaud, Matteo Maule   +2 more
exaly   +3 more sources

Onset of ANCA-Positive EGPA With Bilateral Pleural Effusion: A Case Report

Current Medical Research and Opinion
Background: Eosinophilic granulomatosis with polyangiitis (EGPA) is a multisystemic, immune-mediated disease that occurs in patients with asthma and eosinophilia. It is characterized by inflammation of small- and medium-caliber blood vessels.
Rocco Accogli
exaly   +2 more sources

A Rare Case of Sudden Blindness Following Mepolizumab Withdrawal in EGPA

Current Medical Research and Opinion
Background: Eosinophilic granulomatosis with polyangiitis (EGPA) is a small-vessel vasculitis primarily affecting individuals with asthma and hypereosinophilia. Among the available treatment options for EGPA, biological therapies such as Mepolizumab have
Alfredo Chetta, Marina Aiello, Annalisa Frizzelli   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Heart Disease in Eosinophilic Granulomatosis With Polyangiitis (EGPA) Patients: A Screening Approach Proposal.

Rheumatology, 2021
Eloi Garcia-Vives, David Jane, Roser Solans-Laqué   +2 more
exaly  

Renal Involvement in Eosinophilic Granulomatosis With Polyangiitis (EGPA): A Multicentric Retrospective Study of 63 Biopsy-Proven Cases

Rheumatology, 2021
Daniel Blockmans, David Jane, Xavier Puechal   +2 more
exaly  

Endomyocardial Biopsy Facilitates Diagnosis of Eosinophilic Granulomatosis With Polyangiitis (EGPA): A Case Report

Cardiovascular Pathology, 2022
Heather L Stevenson, Alyeesha B Wilhelm, Arwyn Cunningham   +2 more
exaly  

Omalizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA): Single-Center Experience in 18 Cases

World Allergy Organization Journal, 2018
Dilşad Mungan, Ömür Aydın, Zeynep Celebi Sozener   +2 more
exaly  

Role of Cytokines in EGPA and the Possibility of Treatment With an Anti-IL-5 Antibody

Journal of Clinical Medicine, 2020
Tsuyoshi Kasama, Takeo Isozaki, Hironori Sagara   +2 more
exaly  

Comprehensive Evaluation of Cardiac Involvement in Eosinophilic Granulomatosis With Polyangiitis (EGPA) With Cardiac Magnetic Resonance

European Journal of Internal Medicine, 2017
Alberto Francesco Cereda, Lucio De Capitani, Patrizia Pedrotti   +2 more
exaly  

Heart Failure Not Responsive to Standard Immunosuppressive Therapy Is Successfully Treated With High Dose Intravenous Immunoglobulin Therapy in a Patient With Eosinophilic Granulomatosis With Polyangiitis (EGPA)

International Immunopharmacology, 2017
Laura Carucci, Giuseppe Spadaro, Antonio Pecoraro   +2 more
exaly